Save time and get answers to complex questions with AI chat
How many years does kadcyla's market exclusivity last?Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Brenzavvy discontinuation?Is allopurinol expensive?Motegrity ingredients?
See the DrugPatentWatch profile for cosentyx
Based on the available information, Cosentyx (secukinumab) dosing is not described as being adjusted purely due to body weight or being a “heavyweight” patient. The labeled dosing approach is based on the specific condition being treated (for example, plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, or non-radiographic axial spondyloarthritis), not body weight. 1
For Cosentyx, dosing schedules generally follow the treatment indication and the standard initiation/maintenance regimen for that indication. If a patient’s condition is one that uses a loading/maintenance schedule, the dose and timing follow that schedule rather than a body-weight adjustment. 1
Dosing can still vary due to factors other than weight, such as the exact diagnosis and whether you are using the subcutaneous injection regimen or an intravenous formulation (if applicable for your indication). Checking the dosing section of the official prescribing information for your condition is the most reliable way to confirm whether any dose adjustments apply in your case. 1
Other Questions About Cosentyx :